SavedAdd your journal

Journals / Retina-Vitreus / 2011 / Cilt: 19 - Sayı: 1

Choroidal neovascularization in group 2A idiopathic juxtafoveal retinal telangiectasis and treatment with ranibizumab

Tip 2A idiopatik jukstafoveal retina telenjiektazi olgusunda gelişen koroid neovaskülarizasyonu ve intravitreal ranibizumab ile tedavisi

Rengin Aslıhan KURT
Figen BATIOĞLU
Emin ÖZMERT
Pages
71–74
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case report we studied the importance of different imaging techniques for macular evaluation in treatment and prognosis of choroidal neovascularization due to group 2A idiopathic juxtafoveal retinal telangiectasis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A 48-year-old otherwise healthy woman who presented with metamorphopsia in her right eye was diagnosed with idiopathic juxtafoveal retinal telangiectasis (IJRT) after complete ophthalmologic examination, fundus fluorescein angiography (FFA) with Heidelberg Retinal Angiography (2) fundus autofluorescence findings and cross sectional view of the macula with spectral optical coherence tomography (OCT).
📊
Key Findings & Data:The patient underwent 3 times intravitreal ranibizumab injection monthly.
💡
Conclusion & Impact:In this case report we studied the importance of different imaging techniques for macular evaluation in treatment and prognosis of choroidal neovascularization due to group 2A idiopathic juxtafoveal retinal telangiectasis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A 48-year-old otherwise healthy woman who presented with metamorphopsia in her right eye was diagnosed with idiopathic juxtafoveal retinal telangiectasis (IJRT) after complete ophthalmologic examination, fundus fluorescein angiography (FFA) with Heidelberg Retinal Angiography (2) fundus autofluorescence findings and cross sectional view of the macula with spectral optical coherence tomography (OCT). Choroidal nevascularization due to IJRT was diagnosed during the follow-up. The patient underwent 3 times intravitreal ranibizumab injection monthly. In this case report we studied the importance of different imaging techniques for macular evaluation in treatment and prognosis of choroidal neovascularization due to group 2A idiopathic juxtafoveal retinal telangiectasis.

Özet

Sağ gözde metamorfopsi şikayetiyle başvuran diğer yönlerden sağlıklı 48 yaşında kadın olguya tam oftalmolojik muayeneyi takiben Heidelberg Retinal Anjiografi (2) cihazı ile çekilen fundus flöresein anjiografi ile fundus otoflöresans (FAF) görüntüleri ve spektral optik koherens tomografi (OKT) ile alınan makula kesitleri değerlendirilerek Tip 2A idiopatik jukstafoveal retinal telenjiektazi (IJRT) tanısı kondu. Takiplerde sağ gözde görme azalması şikayeti gelişen olguda IJRT’ye ikincil koroid neovaskülarizasyonu (KNV) saptandı ve 1 ay aralıklarla 3 kez intravitreal ranibizumab uygulandı. Bu olgu sunumunda IJRT tanısı ile takip edilmekte olan bir olguda gelişen koroid neovaskülarizasyonu tanı ve tedavisinde farklı görüntüleme yöntemlerinin kullanımı irdelendi.

🔖

Cite This Article

KURT, R. A., BATIOĞLU, F., ÖZMERT, E. (2011). Choroidal neovascularization in group 2A idiopathic juxtafoveal retinal telangiectasis and treatment with ranibizumab. Retina-Vitreus, Cilt: 19 - Sayı: 1, 71–74. https://ajindex.com/articles/307700

References (12)

  1. Gass JD, Oyakawa RT.: Idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol. 1982;100:769-780
  2. Gass JD, Blodi BA.: Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology. 1993;100:1536-1546
  3. Engelbrecht NE, Aaberg TM Jr, Sung J, et al.: Neovascular membranes associated with idiopathic juxtafoveolar telangiectasis. Arch Ophthalmol. 2002;120:320-324
  4. Karagiannis D, Georgalas I, Ladas I, et al.: A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis. Clin Interv Aging. 2009;4:63-65
  5. Paunescu LA, Ko TH, Duker JS, et al.: Idiopathic juxtafoveal retinal telangiectasis: new findings by ultrahigh-resolution optical coherence tomography. Ophthalmology. 2006;113:48-57
  6. Cohen SM, Cohen ML, El-Jabali F, et al.: Optical coherence tomography findings in nonproliferative group 2a idiopathic juxtafoveal retinal telangiectasis. Retina. 2007;27:59-66
  7. H.M. Helb, P. Charbel Issa, et al.: Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia, Retina. 2008;28:808-816
  8. Wong WT, Forooghian F, Majumdar Z, et al.: Fundus autofluorescence in type 2 idiopathic macular telangiectasia: correlation with optical coherence tomography and microperimetry. Am J Ophthalmol. 2009;148:573-583
  9. Ruys J, De Laey JJ, Vanderhaeghen Y, et al.: Intravitreal bevacizumab (Avastin) for the treatment of bilateral acquired juxtafoveal retinal telangiectasis associated with choroidal neovascular membrane. Eye. 2007;21:1433-1434
  10. Jorge R, Costa RA, Calucci D, et al.: Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis. Graefes Arch Clin Exp Ophthalmol. 2007;245:1045-1048
  11. Rishi P, Shroff D, Rishi E.: Combined photodynamic therapy and intravitreal ranibizumab as primary treatment for subretinal neovascular membrane associated with type 2 idiopathic macular telangiectasia. Graefes Arch Clin Exp Ophthalmol. 2008;246:619-621
  12. Park D, Schatz H, McDonald HR, et al.: Fibrovascular tissue in bilateral juxtafoveal telangiectasis. Arch Ophthalmol. 1996;114:1092-1096.